| Literature DB >> 29120391 |
Laetitia Nivelle1, Jane Hubert2, Eric Courot3, Nicolas Borie4, Jean-Hugues Renault5, Jean-Marc Nuzillard6, Dominique Harakat7, Christophe Clément8, Laurent Martiny9, Dominique Delmas10, Philippe Jeandet11, Michel Tarpin12.
Abstract
A new resveratrol dimer (1) called labruscol, has been purified by centrifugal partition chromatography of a crude ethyl acetate stilbene extract obtained from elicited grapevine cell suspensions of Vitis labrusca L. cultured in a 14-liter stirred bioreactor. One dimensional (1D) and two dimensional (2D) nuclear magnetic resonance (NMR) analyses including ¹H, 13C, heteronuclear single-quantum correlation (HSQC), heteronuclear multiple bond correlation (HMBC), and correlation spectroscopy (COSY) as well as high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS) were used to characterize this compound and to unambiguously identify it as a new stilbene dimer, though its relative stereochemistry remained unsolved. Labruscol was recovered as a pure compound (>93%) in sufficient amounts (41 mg) to allow assessment of its biological activity (cell viability, cell invasion and apoptotic activity) on two different cell lines, including one human skin melanoma cancer cell line HT-144 and a healthy human dermal fibroblast (HDF) line. This compound induced almost 100% of cell viability inhibition in the cancer line at a dose of 100 μM within 72 h of treatment. However, at all tested concentrations and treatment times, resveratrol displayed an inhibition of the cancer line viability higher than that of labruscol in the presence of fetal bovine serum. Both compounds also showed differential activities on healthy and cancer cell lines. Finally, labruscol at a concentration of 1.2 μM was shown to reduce cell invasion by 40%, although no similar activity was observed with resveratrol. The cytotoxic activity of this newly-identified dimer is discussed.Entities:
Keywords: Vitis labrusca L.; bioreactor; cytotoxic activity; fibroblasts; labruscol; melanoma; resveratrol
Mesh:
Substances:
Year: 2017 PMID: 29120391 PMCID: PMC6150286 DOI: 10.3390/molecules22111940
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure and nuclear magnetic resonance (NMR) data for labruscol (1).
Figure 2Effects of resveratrol and labruscol on cell viability and cell invasion in HT-144 and HDF cells. (A) HT-144 cells were treated with resveratrol and labruscol (0, 25, 50, 100 and 200 µM) in the presence of fetal bovine serum (FBS) for 24, 48 and 72 h before being subjected to an MTT (3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyltetrazolium bromide) assay for cell viability determination. The values represented the means ± standard deviation (SD) of at least three independent experiments; (B) Human dermal fibroblast cells were treated with resveratrol and labruscol (0, 25, 50, 100 and 200 µM) for 24, 48 and 72 h before being subjected to an MTT assay for cell viability determination. The values represented the means ± SD of at least three independent experiments; (C) Determination of the inhibiting concentration (IC5 values of resveratrol and labruscol. HT-144 cells were treated in a medium without FBS with resveratrol (0, 1.5, 10, 15, 30, 60 and 120 µM) and labruscol (0, 1.5, 2, 2.5, 5, 8 µM) for 24 h before being subjected to an MTT assay for IC5 determination. The values represented the means ± SD of at least three independent experiments. Straight lines correspond to the IC5; (D) Determination of cell invasion abilities. Cell invasion was measured using a Boyden chamber for 24 h with a matrigel® coating (25 µg/mL). HT-144 cells were treated in an FBS-free medium with vehicle (ethanol), resveratrol (2 µM) or labruscol (1.2 µM) for 24 h. The invasion abilities of HT-144 cells were quantified by counting the number of cells that invaded the underside of the transwell, as described in the Material and Methods section. The invasive activity of cancer cells was expressed as the mean number of cells that crossed the matrigel. The values represented the means ± SD of at least three independent experiments. * p < 0.05, compared with the vehicle group.
Figure 3Apoptosis induction by resveratrol and labruscol in human skin melanoma cancer cells. Cells were treated during 48 h or 72 h with 50 μM resveratrol or labruscol. Apoptosis was assessed by staining (control cells or cells treated with resveratrol or labruscol) with 1 μg/mL Hoechst 33342. Co: control cells; RSV: resveratrol-treated cells; Labruscol: labruscol-treated cells. The values represented the means ± SD of at least 3 independent experiments. *** p < 0.05, compared with the control group.